Literature DB >> 20321575

ANURIA CAUSED BY SULFAPYRIDINE THERAPY : (Report of a Case Successfully Treated by Operation).

E Smith1, K A Evelyn, J F Nolan.   

Abstract

Entities:  

Year:  1940        PMID： 20321575      PMCID： PMC537682     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  3 in total

1.  OBSERVATIONS ON THE ABSORPTION, DISTRIBUTION AND EXCRETION OF SULPHAPYRIDINE, DAGENAN OR M. & B. 693.

Authors:  W H Brown; W B Thornton; J S Wilson
Journal:  J Clin Invest       Date:  1939-11       Impact factor: 14.808

2.  THE TREATMENT OF PNEUMOCOCCAL PNEUMONIA WITH DAGENAN (M. & B. 693).

Authors:  D Graham; W P Warner; J A Dauphinee; R C Dickson
Journal:  Can Med Assoc J       Date:  1939-04       Impact factor: 8.262

3.  THE TREATMENT OF PNEUMOCOCCIC PNEUMONIA WITH SULFAPYRIDINE (DAGENAN).

Authors:  J M Kilgour
Journal:  Can Med Assoc J       Date:  1939-11       Impact factor: 8.262
  3 in total
  3 in total

1.  Additional manifestation of sulphathiazole toxicity: Non-Calculous Renal Insufficiency Following the use of sulphathiazole.

Authors:  E Press; M Kennerstein
Journal:  Arch Dis Child       Date:  1943-03       Impact factor: 3.791

2.  Sulfonamide Anuria.

Authors:  J T Maclean
Journal:  Can Med Assoc J       Date:  1944-12       Impact factor: 8.262

3.  II. Pathological Evidence as to the Causation of Hæmaturia following Sulphapyridine Therapy.

Authors:  N T Whitehead
Journal:  Br J Vener Dis       Date:  1942-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.